a clinical stage drug discovery and development biotech 

We are dedicated to discovering and developing novel small molecule therapeutics for the treatment of intractable diseases. Utilizing a target-centric approach, innovative screening schemes and traditional wet-lab chemistry and pharmacology, Curadev has built an impressive portfolio of discovery research programs, resulting in patent-protected drug candidates that modulate next-generation drug targets.

Clinical Trials

CURADEV IN THE NEWS 

 

Memorial Sloan Kettering Cancer Center and Curadev are expanding their collaboration through the MSK Therapeutics Accelerator program to expand the Phase 1 clinical trial currently underway at MSK with CRD3874-SI, Curadev’s first-in-class allosteric STING agonist, to several types of cancers

News Update